Pharmaceuticals

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping the 225mg, 325mg, and 425mg strengths of propafenone SR capsules, the generic version of GlaxoSmithKline's Rythmol SR. Par has been awarded 180 days of marketing exclusivity, commencing at launch, for being the...

Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping all strengths of amlodipine besylate and benazepril hydrochloride capsules, the generic version of Novartis' Lotrel. Par has been awarded 180 days of marketing exclusivity for the 5/320mg and 10/320mg strengths...

Pfizer Inc.(PFE) recently announced its decision to acquire Synbiotics Corp. which will form a part of Pfizer's Animal Health unit, for an undisclosed amount. Kansas City based company, Synbiotics, is a leader in the manufacturing of immunodiagnostic tests for animals. The addition of...

Pfizer Inc.(PFE) recently announced its decision to acquire Synbiotics Corp. which will form a part of Pfizer's Animal Health unit, for an undisclosed amount. Kansas City based company, Synbiotics, is a leader in the manufacturing of immunodiagnostic tests for animals. The addition of...

Pfizer Inc.(PFE) recently announced its decision to acquire Synbiotics Corp. which will form a part of Pfizer's Animal Health unit, for an undisclosed amount. Kansas City based company, Synbiotics, is a leader in the manufacturing of immunodiagnostic tests for animals. The addition of...

Pfizer Inc.(PFE) recently announced its decision to acquire Synbiotics Corp. which will form a part of Pfizer's Animal Health unit, for an undisclosed amount. Kansas City based company, Synbiotics, is a leader in the manufacturing of immunodiagnostic tests for animals. The addition of...

Inspire Pharmaceuticals Inc (NASDAQ: ISPH) dipped 57.98% to $3.53 at 10:10 am. ISPH reported that its experimental treatment for cystic fibrosis did not meet treatment goals in a late-stage study. China GengSheng Minerals Inc (AMEX: CHGS) fell 12.82% to $4.49. CHGS' trailing-twelve-month ROA is 2....

• Goldman Sachs (NYSE:GS) has invested $450.0 million in social networking firm Facebook, and is planning to  invest another $1.5 billion, making the value of the site at about $50 billion • Bank of America (NYSE:BAC) has reported fourth quarter charges of $3 billion on its GSE exposure, and $2...

• Goldman Sachs (NYSE:GS) has invested $450.0 million in social networking firm Facebook, and is planning to  invest another $1.5 billion, making the value of the site at about $50 billion • Bank of America (NYSE:BAC) has reported fourth quarter charges of $3 billion on its GSE exposure, and $2...

Inspire Pharmaceuticals Inc (NASDAQ: ISPH) dipped 56.55% to $3.65 in the pre-market session. ISPH reported that its experimental treatment for cystic fibrosis did not meet treatment goals in a late-stage study. DryShips Inc (NASDAQ: DRYS) lost 2.37% to $5.36 in the pre-market session. DRYS'...

Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the top-line results from its second Phase 3 clinical trial, TIGER-2, with denufosol tetrasodium for the treatment of cystic fibrosis.

Here is our latest update on the stock trading technique called 'Buying Dividends'. This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only...

Cusick's Corner The market did as expected into the After Hours -- nothing. As we look towards 2011, this new year might shape up to be a trading year. Being nimble and disciplined are going to be the keys to trading in 2011 (the market will probably be one in which you will have to reassess your...